Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.4K
Overview
80.4K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

228
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
228
Physiological Barriers01:25

Physiological Barriers

5.3K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.3K
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

2.5K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.5K
Barriers to Effective Communication II01:21

Barriers to Effective Communication II

5.1K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing the effects of MSC lipid remodeling via sphingomyelinase licensing through morphological, metabolic, and secretome profiling.

Cytotherapy·2026
Same author

Bone marrow-derived mesenchymal stromal cells yield greater pain relief and tissue protection than umbilical cord tissue-derived cells in a surgically induced instability model of osteoarthritis.

Osteoarthritis and cartilage·2026
Same author

Exogenous sphingomyelinase mediates MSC-derived EV biogenesis and enhances potency via repackaging of molecular cargo.

iScience·2026
Same author

Foundation model cascades enable zero-shot microscopy image analysis for cell therapy manufacturing.

Cytotherapy·2026
Same author

Synthetic living materials in cancer biology.

Nature reviews bioengineering·2026
Same author

Single-cell transcriptomics of multi-site cell therapy in osteoarthritis: Tissue-specific treatment correlations.

Molecular therapy. Nucleic acids·2026

Related Experiment Video

Updated: Feb 15, 2026

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering
10:27

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering

Published on: July 10, 2016

9.6K

Engineering nanoparticles to overcome barriers to immunotherapy.

Randall Toy1, Krishnendu Roy1

  • 1Wallace H. Coulter Dept. of Biomedical Engineering Georgia Institute of Technology, and Emory University Atlanta GA 30332.

Bioengineering & Translational Medicine
|January 10, 2018
PubMed
Summary

Designing effective immunotherapies requires careful nanoparticle selection. Understanding nanoparticle properties like size, shape, and surface charge is crucial for targeted delivery and controlling immune responses in cancer immunotherapy and vaccine development.

Keywords:
cancer immunotherapydrug deliveryintracellular deliverytargeted nanoparticlestissue permeationvaccines

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.0K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K

Related Experiment Videos

Last Updated: Feb 15, 2026

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering
10:27

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering

Published on: July 10, 2016

9.6K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.0K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Materials Science

Background:

  • Immunotherapy offers promising treatments but faces challenges in targeted delivery and controlled release.
  • Nanoparticles are increasingly explored as carriers for immunotherapies, offering benefits like controlled biodistribution and site-specific targeting.
  • However, challenges such as non-specific uptake and immune activation must be addressed for effective nanoparticle-mediated immunotherapy.

Purpose of the Study:

  • To review the critical relationship between nanoparticle characteristics and their performance in immunotherapy delivery.
  • To highlight the importance of rational design in selecting nanoparticle physical properties and surface functionalization.
  • To discuss the application of these design principles in vaccine development and cancer immunotherapy.

Main Methods:

  • Review of existing literature on nanoparticle drug delivery and immunotherapy.
  • Analysis of the impact of nanoparticle size, shape, charge, ligand density, and elasticity on vascular transport, biodistribution, and cellular internalization.
  • Discussion of surface functionalization strategies, including chemical modifications, targeting ligands, and stimuli-sensitive materials.

Main Results:

  • Nanoparticle characteristics significantly influence vascular transport, biodistribution, cellular uptake, and immunogenicity.
  • Rational design considering nanoparticle physical properties and surface chemistry is essential for optimizing immunotherapy efficacy.
  • Effective strategies involve tailoring nanoparticles to the target microenvironment and desired therapeutic outcome.

Conclusions:

  • Understanding the interplay between nanoparticle properties and biological interactions is key to overcoming current immunotherapy limitations.
  • A rational nanoparticle design approach, considering physical characteristics and surface functionalization, is vital for developing advanced immunotherapies.
  • This approach holds significant potential for enhancing vaccine development and cancer immunotherapy efficacy.